Brief: Adocia FY net result turns to loss of 7.9 million euros

Adocia SA

07/03/2017 17:00

March 7 (Reuters) - Adocia SA  ADOC.PA : 
    * Financial results for 2016 and its perspectives for 2017 
    * FY net loss 7.9 million euros ($8.36 million) versus profit 12.6 million euros year ago 
    * Regarding BioChaperone Combo co is currently preparing first dose-response study in people 
with type 1 diabetes 
    * Regarding BioChaperone Combo expects to launch second outpatient repeated administration 
study in people with type 2 diabetes during Q4 2017 
    * Regarding new programs objective is to initiate first-in-man studies for BioChaperone 
Glucagon and one BioChaperone Glargine GLP-1 product before end of year 
    * Early in 2017 co announced initiation of two new multi-hormonal combination projects for 
treatment of type 1 diabetes; aims to initiate first clinical study during Q4 2017 
 
Source text for Eikon:  ID:nBw1sMBZya  
Further company coverage:  ADOC.PA  
 
($1 = 0.9450 euros) 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))